1. Home
  2. DMAC vs HQI Comparison

DMAC vs HQI Comparison

Compare DMAC & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DMAC
  • HQI
  • Stock Information
  • Founded
  • DMAC 2000
  • HQI 2002
  • Country
  • DMAC United States
  • HQI United States
  • Employees
  • DMAC N/A
  • HQI N/A
  • Industry
  • DMAC Biotechnology: Pharmaceutical Preparations
  • HQI Professional Services
  • Sector
  • DMAC Health Care
  • HQI Consumer Discretionary
  • Exchange
  • DMAC Nasdaq
  • HQI Nasdaq
  • Market Cap
  • DMAC 172.7M
  • HQI 196.4M
  • IPO Year
  • DMAC N/A
  • HQI N/A
  • Fundamental
  • Price
  • DMAC $4.18
  • HQI $14.99
  • Analyst Decision
  • DMAC Strong Buy
  • HQI Strong Buy
  • Analyst Count
  • DMAC 3
  • HQI 2
  • Target Price
  • DMAC $7.00
  • HQI $18.00
  • AVG Volume (30 Days)
  • DMAC 46.2K
  • HQI 16.6K
  • Earning Date
  • DMAC 11-13-2024
  • HQI 11-07-2024
  • Dividend Yield
  • DMAC N/A
  • HQI 1.67%
  • EPS Growth
  • DMAC N/A
  • HQI N/A
  • EPS
  • DMAC N/A
  • HQI 0.10
  • Revenue
  • DMAC N/A
  • HQI $36,279,000.00
  • Revenue This Year
  • DMAC N/A
  • HQI N/A
  • Revenue Next Year
  • DMAC N/A
  • HQI $8.01
  • P/E Ratio
  • DMAC N/A
  • HQI $102.98
  • Revenue Growth
  • DMAC N/A
  • HQI 0.28
  • 52 Week Low
  • DMAC $2.14
  • HQI $11.39
  • 52 Week High
  • DMAC $4.95
  • HQI $17.31
  • Technical
  • Relative Strength Index (RSI)
  • DMAC 48.23
  • HQI 60.07
  • Support Level
  • DMAC $3.96
  • HQI $14.22
  • Resistance Level
  • DMAC $4.21
  • HQI $14.85
  • Average True Range (ATR)
  • DMAC 0.18
  • HQI 0.62
  • MACD
  • DMAC -0.02
  • HQI 0.08
  • Stochastic Oscillator
  • DMAC 50.00
  • HQI 100.00

About DMAC DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

About HQI HireQuest Inc. (DE)

HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The primary source of revenue for the company is royalty fees based on the operation of its franchised offices.

Share on Social Networks: